Skip to main content
Premium Trial:

Request an Annual Quote

EU to Fund 'Omics Studies for Screening AIDS Drug Candidates

NEW YORK (GenomeWeb News) — The European Commission will spend €3 million ($3.8 million) to fund AIDS research studies that will use or develop genomics and proteomics technologies, among others, aimed at developing new HIV/AIDS treatments.

The project, which is funded under the Seventh Framework program, will support studies to develop assays and drug screening technologies, as well as research on early drug candidates with acceptable toxicity profiles.

Other research could include elucidation of 3D structures of validated targets and rational drug design guided by molecular modeling and docking of inhibitors, and validation and exploitation of the HIV-susceptible transgenic rat models to allow in vivo evaluation of novel drug candidates from the HIV-ACE program.

The project will start March 1 and run through February 2011.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.